HE
HEAL.LSE iShares Healthcare Innovation UCITS ETF USD (Acc)
- USD
No recent price
- Total assets
- 995M
- Expense ratio
- 0.39%
- Dividend yield
- -
- 1-year return
- +34.14%
- Holdings
- 195
- Since
- 2016
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does HEAL.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (72.6%)
- Largest sector: Healthcare (98.8%)
- Largest region: North America (73.7%)
- Top 3 holdings: 10.3% of the fund
Asset allocation
- US stocks 72.6%
- Non-US stocks 27.4%
- Cash 0.4%
Top holdings
- Moderna Inc 5.30%
- Genmab A/S 2.81%
- Natera Inc 2.14%
- Revvity Inc. 1.74%
- Guardant Health Inc 1.67%
iShares Healthcare Innovation UCITS ETF USD (Acc) performance
Sharpe ratio 0.00- This year
- +27.48%
- 1 year
- +34.14%
- 3 years
- +22.13%
- 5 years
- +2.62%
Volatility 16.3% over 1 year and 14.9% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
HEAL.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
iShares Healthcare Innovation UCITS ETF USD (Acc) top holdings
21.6% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 5.30% |
| Genmab A/S GMAB.CO | Healthcare | Denmark | 2.81% |
| Natera Inc NTRA.US | Healthcare | United States | 2.14% |
| Revvity Inc. RVTY.US | Healthcare | United States | 1.74% |
| Guardant Health Inc GH.US | Healthcare | United States | 1.67% |
| Illumina Inc ILMN.US | Healthcare | United States | 1.64% |
| Charles River Laboratories CRL.US | Healthcare | United States | 1.63% |
| IQVIA Holdings Inc IQV.US | Healthcare | United States | 1.61% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 1.56% |
| Amgen Inc AMGN.US | Healthcare | United States | 1.54% |
The 10 largest of 195 holdings.
HEAL.LSE sector exposure
- Healthcare98.8%
- Technology1.0%
- Industrials0.4%
- Financial Services0.2%
- Real Estate0.2%
- Basic Materials0.1%
Share of the stocks in the fund.
HEAL.LSE regional exposure
- North America73.7%
- Europe Developed15.5%
- Japan4.4%
- Asia Developed3.7%
- United Kingdom2.8%
- Asia Emerging1.0%
- Australasia0.7%
- Africa/Middle East0.0%
Share of the stocks in the fund.
Company size
Average market cap 22.9B- Mega cap5.1%
- Big cap25.9%
- Medium cap31.4%
- Small cap25.3%
- Micro cap8.9%
iShares Healthcare Innovation UCITS ETF USD (Acc) fund profile
- Fund name
- iShares Healthcare Innovation UCITS ETF USD (Acc)
- Ticker
- HEAL.LSE
- Exchange
- London Exchange
- Fund website
- ishares.com/uk/individual/en/products/284216/ishares-healthcare-innovation-ucits-etf-usd-(acc)-fund
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Sep 8, 2016
- Trading currency
- USD
- Expense ratio
- 0.39%